Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Index by author

June 01, 1986; Volume 29,Issue 6
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Alvarez, R

    1. You have access
      A potent and selective inhibitor of cyclic AMP phosphodiesterase with potential cardiotonic and antithrombotic properties.
      R Alvarez, G L Banerjee, J J Bruno, G L Jones, K Littschwager, A M Strosberg and M C Venuti
      Molecular Pharmacology June 1986, 29 (6) 554-560;
  2. Anundi, I M

    1. You have access
      Hydrolysis of organic sulfates in periportal and pericentral regions of the liver lobule: studies with 4-methylumbelliferyl sulfate in the perfused rat liver.
      I M Anundi, F C Kauffman, M el-Mouelhi and R G Thurman
      Molecular Pharmacology June 1986, 29 (6) 599-605;
  3. Armstrong, R D

    1. You have access
      Precursor-dependent differences in the incorporation of fluorouracil in RNA.
      C H Takimoto, E C Cadman and R D Armstrong
      Molecular Pharmacology June 1986, 29 (6) 637-642;

B

  1. Bachur, N R

    1. You have access
      DNA alkylation by enzyme-activated mitomycin C.
      S S Pan, T Iracki and N R Bachur
      Molecular Pharmacology June 1986, 29 (6) 622-628;
  2. Banerjee, G L

    1. You have access
      A potent and selective inhibitor of cyclic AMP phosphodiesterase with potential cardiotonic and antithrombotic properties.
      R Alvarez, G L Banerjee, J J Bruno, G L Jones, K Littschwager, A M Strosberg and M C Venuti
      Molecular Pharmacology June 1986, 29 (6) 554-560;
  3. Bolger, M B

    1. You have access
      Haloperidol binding to monoclonal antibodies: conformational analysis and relationships to D-2 receptor binding.
      M A Sherman, D S Linthicum and M B Bolger
      Molecular Pharmacology June 1986, 29 (6) 589-598;
  4. Boyd, N D

    1. You have access
      Location of a polypeptide sequence within the alpha-subunit of the acetylcholine receptor containing the cholinergic binding site.
      B Oblas, R H Singer and N D Boyd
      Molecular Pharmacology June 1986, 29 (6) 649-656;
  5. Brown, R D

    1. You have access
      Alpha 1-adrenergic and H1-histamine receptor control of intracellular Ca2+ in a muscle cell line: the influence of prior agonist exposure on receptor responsiveness.
      R D Brown, P Prendiville and C Cain
      Molecular Pharmacology June 1986, 29 (6) 531-539;
  6. Bruno, J J

    1. You have access
      A potent and selective inhibitor of cyclic AMP phosphodiesterase with potential cardiotonic and antithrombotic properties.
      R Alvarez, G L Banerjee, J J Bruno, G L Jones, K Littschwager, A M Strosberg and M C Venuti
      Molecular Pharmacology June 1986, 29 (6) 554-560;

C

  1. Cadman, E C

    1. You have access
      Precursor-dependent differences in the incorporation of fluorouracil in RNA.
      C H Takimoto, E C Cadman and R D Armstrong
      Molecular Pharmacology June 1986, 29 (6) 637-642;
  2. Cain, C

    1. You have access
      Alpha 1-adrenergic and H1-histamine receptor control of intracellular Ca2+ in a muscle cell line: the influence of prior agonist exposure on receptor responsiveness.
      R D Brown, P Prendiville and C Cain
      Molecular Pharmacology June 1986, 29 (6) 531-539;
  3. Cantoni, O

    1. You have access
      Characterization of DNA lesions induced by CaCrO4 in synchronous and asynchronous cultured mammalian cells.
      M Sugiyama, S R Patierno, O Cantoni and M Costa
      Molecular Pharmacology June 1986, 29 (6) 606-613;
  4. Conn, P M

    1. You have access
      Hormone-stimulated redistribution of gonadotrope protein kinase C in vivo: dependence on Ca2+ influx.
      C A McArdle and P M Conn
      Molecular Pharmacology June 1986, 29 (6) 570-576;
  5. Costa, M

    1. You have access
      Characterization of DNA lesions induced by CaCrO4 in synchronous and asynchronous cultured mammalian cells.
      M Sugiyama, S R Patierno, O Cantoni and M Costa
      Molecular Pharmacology June 1986, 29 (6) 606-613;

D

  1. Dolnick, B J

    1. You have access
      5-Fluorouracil augmentation of dihydrofolate reductase gene transcripts containing intervening sequences in methotrexate-resistant KB cells.
      C L Will and B J Dolnick
      Molecular Pharmacology June 1986, 29 (6) 643-648;

E

  1. el-Mouelhi, M

    1. You have access
      Hydrolysis of organic sulfates in periportal and pericentral regions of the liver lobule: studies with 4-methylumbelliferyl sulfate in the perfused rat liver.
      I M Anundi, F C Kauffman, M el-Mouelhi and R G Thurman
      Molecular Pharmacology June 1986, 29 (6) 599-605;

H

  1. Hagiwara, M

    1. You have access
      Naphthalenesulfonamides as calmodulin antagonists and protein kinase inhibitors.
      M Inagaki, S Kawamoto, H Itoh, M Saitoh, M Hagiwara, J Takahashi and H Hidaka
      Molecular Pharmacology June 1986, 29 (6) 577-581;
  2. Hidaka, H

    1. You have access
      Naphthalenesulfonamides as calmodulin antagonists and protein kinase inhibitors.
      M Inagaki, S Kawamoto, H Itoh, M Saitoh, M Hagiwara, J Takahashi and H Hidaka
      Molecular Pharmacology June 1986, 29 (6) 577-581;
  3. Hughes, R J

    1. You have access
      Agonist-mediated regulation of alpha 1- and beta 2-adrenergic receptor metabolism in a muscle cell line, BC3H-1.
      R J Hughes and P A Insel
      Molecular Pharmacology June 1986, 29 (6) 521-530;

I

  1. Inagaki, M

    1. You have access
      Naphthalenesulfonamides as calmodulin antagonists and protein kinase inhibitors.
      M Inagaki, S Kawamoto, H Itoh, M Saitoh, M Hagiwara, J Takahashi and H Hidaka
      Molecular Pharmacology June 1986, 29 (6) 577-581;
  2. Insel, P A

    1. You have access
      Agonist-mediated regulation of alpha 1- and beta 2-adrenergic receptor metabolism in a muscle cell line, BC3H-1.
      R J Hughes and P A Insel
      Molecular Pharmacology June 1986, 29 (6) 521-530;
  3. Iracki, T

    1. You have access
      DNA alkylation by enzyme-activated mitomycin C.
      S S Pan, T Iracki and N R Bachur
      Molecular Pharmacology June 1986, 29 (6) 622-628;
  4. Itoh, H

    1. You have access
      Naphthalenesulfonamides as calmodulin antagonists and protein kinase inhibitors.
      M Inagaki, S Kawamoto, H Itoh, M Saitoh, M Hagiwara, J Takahashi and H Hidaka
      Molecular Pharmacology June 1986, 29 (6) 577-581;

J

  1. Jones, G L

    1. You have access
      A potent and selective inhibitor of cyclic AMP phosphodiesterase with potential cardiotonic and antithrombotic properties.
      R Alvarez, G L Banerjee, J J Bruno, G L Jones, K Littschwager, A M Strosberg and M C Venuti
      Molecular Pharmacology June 1986, 29 (6) 554-560;

K

  1. Kamaya, H

    1. You have access
      Anesthetics release unfreezable and bound water in partially hydrated phospholipid lamellar systems and elevate phase transition temperature.
      I Ueda, H S Tseng, Y Kaminoh, S M Ma, H Kamaya and S H Lin
      Molecular Pharmacology June 1986, 29 (6) 582-588;
  2. Kaminoh, Y

    1. You have access
      Anesthetics release unfreezable and bound water in partially hydrated phospholipid lamellar systems and elevate phase transition temperature.
      I Ueda, H S Tseng, Y Kaminoh, S M Ma, H Kamaya and S H Lin
      Molecular Pharmacology June 1986, 29 (6) 582-588;
  3. Kauffman, F C

    1. You have access
      Hydrolysis of organic sulfates in periportal and pericentral regions of the liver lobule: studies with 4-methylumbelliferyl sulfate in the perfused rat liver.
      I M Anundi, F C Kauffman, M el-Mouelhi and R G Thurman
      Molecular Pharmacology June 1986, 29 (6) 599-605;
  4. Kawamoto, S

    1. You have access
      Naphthalenesulfonamides as calmodulin antagonists and protein kinase inhibitors.
      M Inagaki, S Kawamoto, H Itoh, M Saitoh, M Hagiwara, J Takahashi and H Hidaka
      Molecular Pharmacology June 1986, 29 (6) 577-581;
  5. Keys, C

    1. You have access
      Structure-activity studies of morphiceptin analogs: receptor binding and molecular determinants of mu-affinity and selectivity.
      G Loew, C Keys, B Luke, W Polgar and L Toll
      Molecular Pharmacology June 1986, 29 (6) 546-553;
  6. Kuczenski, R

    1. You have access
      Dopamine autoreceptor regulation of the kinetic state of striatal tyrosine hydroxylase.
      K A Strait and R Kuczenski
      Molecular Pharmacology June 1986, 29 (6) 561-569;

L

  1. Larsson, A

    1. You have access
      Inhibition of herpes simplex virus-induced DNA polymerases and cellular DNA polymerase alpha by triphosphates of acyclic guanosine analogs.
      A Larsson, A Sundqvist and A M Parnerud
      Molecular Pharmacology June 1986, 29 (6) 614-621;
  2. Lin, S H

    1. You have access
      Anesthetics release unfreezable and bound water in partially hydrated phospholipid lamellar systems and elevate phase transition temperature.
      I Ueda, H S Tseng, Y Kaminoh, S M Ma, H Kamaya and S H Lin
      Molecular Pharmacology June 1986, 29 (6) 582-588;
  3. Linthicum, D S

    1. You have access
      Haloperidol binding to monoclonal antibodies: conformational analysis and relationships to D-2 receptor binding.
      M A Sherman, D S Linthicum and M B Bolger
      Molecular Pharmacology June 1986, 29 (6) 589-598;
  4. Littschwager, K

    1. You have access
      A potent and selective inhibitor of cyclic AMP phosphodiesterase with potential cardiotonic and antithrombotic properties.
      R Alvarez, G L Banerjee, J J Bruno, G L Jones, K Littschwager, A M Strosberg and M C Venuti
      Molecular Pharmacology June 1986, 29 (6) 554-560;
  5. Loew, G

    1. You have access
      Structure-activity studies of morphiceptin analogs: receptor binding and molecular determinants of mu-affinity and selectivity.
      G Loew, C Keys, B Luke, W Polgar and L Toll
      Molecular Pharmacology June 1986, 29 (6) 546-553;
  6. Lueddens, H W

    1. You have access
      AHN 086: an irreversible ligand of "peripheral" benzodiazepine receptors.
      H W Lueddens, A H Newman, K C Rice and P Skolnick
      Molecular Pharmacology June 1986, 29 (6) 540-545;
  7. Luke, B

    1. You have access
      Structure-activity studies of morphiceptin analogs: receptor binding and molecular determinants of mu-affinity and selectivity.
      G Loew, C Keys, B Luke, W Polgar and L Toll
      Molecular Pharmacology June 1986, 29 (6) 546-553;

M

  1. Ma, S M

    1. You have access
      Anesthetics release unfreezable and bound water in partially hydrated phospholipid lamellar systems and elevate phase transition temperature.
      I Ueda, H S Tseng, Y Kaminoh, S M Ma, H Kamaya and S H Lin
      Molecular Pharmacology June 1986, 29 (6) 582-588;
  2. Maynard, A T

    1. You have access
      An Ab initio study of the relationship between nitroarene mutagenicity and electron affinity.
      A T Maynard, L G Pedersen, H S Posner and J D McKinney
      Molecular Pharmacology June 1986, 29 (6) 629-636;
  3. McArdle, C A

    1. You have access
      Hormone-stimulated redistribution of gonadotrope protein kinase C in vivo: dependence on Ca2+ influx.
      C A McArdle and P M Conn
      Molecular Pharmacology June 1986, 29 (6) 570-576;
  4. McKinney, J D

    1. You have access
      An Ab initio study of the relationship between nitroarene mutagenicity and electron affinity.
      A T Maynard, L G Pedersen, H S Posner and J D McKinney
      Molecular Pharmacology June 1986, 29 (6) 629-636;

N

  1. Newman, A H

    1. You have access
      AHN 086: an irreversible ligand of "peripheral" benzodiazepine receptors.
      H W Lueddens, A H Newman, K C Rice and P Skolnick
      Molecular Pharmacology June 1986, 29 (6) 540-545;

O

  1. Oblas, B

    1. You have access
      Location of a polypeptide sequence within the alpha-subunit of the acetylcholine receptor containing the cholinergic binding site.
      B Oblas, R H Singer and N D Boyd
      Molecular Pharmacology June 1986, 29 (6) 649-656;

P

  1. Pan, S S

    1. You have access
      DNA alkylation by enzyme-activated mitomycin C.
      S S Pan, T Iracki and N R Bachur
      Molecular Pharmacology June 1986, 29 (6) 622-628;
  2. Parnerud, A M

    1. You have access
      Inhibition of herpes simplex virus-induced DNA polymerases and cellular DNA polymerase alpha by triphosphates of acyclic guanosine analogs.
      A Larsson, A Sundqvist and A M Parnerud
      Molecular Pharmacology June 1986, 29 (6) 614-621;
  3. Patierno, S R

    1. You have access
      Characterization of DNA lesions induced by CaCrO4 in synchronous and asynchronous cultured mammalian cells.
      M Sugiyama, S R Patierno, O Cantoni and M Costa
      Molecular Pharmacology June 1986, 29 (6) 606-613;
  4. Pedersen, L G

    1. You have access
      An Ab initio study of the relationship between nitroarene mutagenicity and electron affinity.
      A T Maynard, L G Pedersen, H S Posner and J D McKinney
      Molecular Pharmacology June 1986, 29 (6) 629-636;
  5. Polgar, W

    1. You have access
      Structure-activity studies of morphiceptin analogs: receptor binding and molecular determinants of mu-affinity and selectivity.
      G Loew, C Keys, B Luke, W Polgar and L Toll
      Molecular Pharmacology June 1986, 29 (6) 546-553;
  6. Posner, H S

    1. You have access
      An Ab initio study of the relationship between nitroarene mutagenicity and electron affinity.
      A T Maynard, L G Pedersen, H S Posner and J D McKinney
      Molecular Pharmacology June 1986, 29 (6) 629-636;
  7. Prendiville, P

    1. You have access
      Alpha 1-adrenergic and H1-histamine receptor control of intracellular Ca2+ in a muscle cell line: the influence of prior agonist exposure on receptor responsiveness.
      R D Brown, P Prendiville and C Cain
      Molecular Pharmacology June 1986, 29 (6) 531-539;

R

  1. Rice, K C

    1. You have access
      AHN 086: an irreversible ligand of "peripheral" benzodiazepine receptors.
      H W Lueddens, A H Newman, K C Rice and P Skolnick
      Molecular Pharmacology June 1986, 29 (6) 540-545;

S

  1. Saitoh, M

    1. You have access
      Naphthalenesulfonamides as calmodulin antagonists and protein kinase inhibitors.
      M Inagaki, S Kawamoto, H Itoh, M Saitoh, M Hagiwara, J Takahashi and H Hidaka
      Molecular Pharmacology June 1986, 29 (6) 577-581;
  2. Sherman, M A

    1. You have access
      Haloperidol binding to monoclonal antibodies: conformational analysis and relationships to D-2 receptor binding.
      M A Sherman, D S Linthicum and M B Bolger
      Molecular Pharmacology June 1986, 29 (6) 589-598;
  3. Singer, R H

    1. You have access
      Location of a polypeptide sequence within the alpha-subunit of the acetylcholine receptor containing the cholinergic binding site.
      B Oblas, R H Singer and N D Boyd
      Molecular Pharmacology June 1986, 29 (6) 649-656;
  4. Skolnick, P

    1. You have access
      AHN 086: an irreversible ligand of "peripheral" benzodiazepine receptors.
      H W Lueddens, A H Newman, K C Rice and P Skolnick
      Molecular Pharmacology June 1986, 29 (6) 540-545;
  5. Strait, K A

    1. You have access
      Dopamine autoreceptor regulation of the kinetic state of striatal tyrosine hydroxylase.
      K A Strait and R Kuczenski
      Molecular Pharmacology June 1986, 29 (6) 561-569;
  6. Strosberg, A M

    1. You have access
      A potent and selective inhibitor of cyclic AMP phosphodiesterase with potential cardiotonic and antithrombotic properties.
      R Alvarez, G L Banerjee, J J Bruno, G L Jones, K Littschwager, A M Strosberg and M C Venuti
      Molecular Pharmacology June 1986, 29 (6) 554-560;
  7. Sugiyama, M

    1. You have access
      Characterization of DNA lesions induced by CaCrO4 in synchronous and asynchronous cultured mammalian cells.
      M Sugiyama, S R Patierno, O Cantoni and M Costa
      Molecular Pharmacology June 1986, 29 (6) 606-613;
  8. Sundqvist, A

    1. You have access
      Inhibition of herpes simplex virus-induced DNA polymerases and cellular DNA polymerase alpha by triphosphates of acyclic guanosine analogs.
      A Larsson, A Sundqvist and A M Parnerud
      Molecular Pharmacology June 1986, 29 (6) 614-621;

T

  1. Takahashi, J

    1. You have access
      Naphthalenesulfonamides as calmodulin antagonists and protein kinase inhibitors.
      M Inagaki, S Kawamoto, H Itoh, M Saitoh, M Hagiwara, J Takahashi and H Hidaka
      Molecular Pharmacology June 1986, 29 (6) 577-581;
  2. Takimoto, C H

    1. You have access
      Precursor-dependent differences in the incorporation of fluorouracil in RNA.
      C H Takimoto, E C Cadman and R D Armstrong
      Molecular Pharmacology June 1986, 29 (6) 637-642;
  3. Thurman, R G

    1. You have access
      Hydrolysis of organic sulfates in periportal and pericentral regions of the liver lobule: studies with 4-methylumbelliferyl sulfate in the perfused rat liver.
      I M Anundi, F C Kauffman, M el-Mouelhi and R G Thurman
      Molecular Pharmacology June 1986, 29 (6) 599-605;
  4. Toll, L

    1. You have access
      Structure-activity studies of morphiceptin analogs: receptor binding and molecular determinants of mu-affinity and selectivity.
      G Loew, C Keys, B Luke, W Polgar and L Toll
      Molecular Pharmacology June 1986, 29 (6) 546-553;
  5. Tseng, H S

    1. You have access
      Anesthetics release unfreezable and bound water in partially hydrated phospholipid lamellar systems and elevate phase transition temperature.
      I Ueda, H S Tseng, Y Kaminoh, S M Ma, H Kamaya and S H Lin
      Molecular Pharmacology June 1986, 29 (6) 582-588;

U

  1. Ueda, I

    1. You have access
      Anesthetics release unfreezable and bound water in partially hydrated phospholipid lamellar systems and elevate phase transition temperature.
      I Ueda, H S Tseng, Y Kaminoh, S M Ma, H Kamaya and S H Lin
      Molecular Pharmacology June 1986, 29 (6) 582-588;

V

  1. Venuti, M C

    1. You have access
      A potent and selective inhibitor of cyclic AMP phosphodiesterase with potential cardiotonic and antithrombotic properties.
      R Alvarez, G L Banerjee, J J Bruno, G L Jones, K Littschwager, A M Strosberg and M C Venuti
      Molecular Pharmacology June 1986, 29 (6) 554-560;

W

  1. Will, C L

    1. You have access
      5-Fluorouracil augmentation of dihydrofolate reductase gene transcripts containing intervening sequences in methotrexate-resistant KB cells.
      C L Will and B J Dolnick
      Molecular Pharmacology June 1986, 29 (6) 643-648;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 29, Issue 6
1 Jun 1986
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics